Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/Beleave Inc.
Company profile

Beleave Inc.

OTC: BLEVF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Oakville, ONReports USD
#1 of 1,402 Healthcare companies by revenue
EA Score
——
FH —DQ —GM —SS 24
v0.1 · 5/100 weight · pillars only
↑ listing tenure, market scale · ↓ market scale, listing tenure
Methodology →
Revenue TTM
—
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
—
Employees
—
Market cap
$566
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Beleave Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare
GlobeImmune, Inc.——Adynxx, Inc.——Sunset Island Group, Inc.——OncoSec Medical Incorporated——
Key facts
CEOVasilios Panagiotakopoulos
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersOakville, ON
ExchangeOTC: BLEVF
Employees—
IPO date2016-09-28
Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies